Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer

Background: Epidemiologic studies have indicated that menstrual cycle characteristics such as age at menarche and age at menopause are associated with breast cancer risk. Anovulation, which is more common with long or irregular cycles, has been hypothesized to reduce the incidence of breast cancer. Methods: We analyzed data from the Nurses' Health Study II, a cohort of 116,671 female registered nurses ages 25 to 42 years at baseline. Information on menstrual cycle characteristics was assessed in 1989 and 1993, and incident cases of premenopausal breast cancer were ascertained through 2001. Results: During 1,135,496 person-years of follow-up (1989-2001), 1,163 incident cases of invasive premenopausal breast cancer were diagnosed. Overall, women with long menstrual cycles at ages 18 to 22 years (>32 days or too irregular to estimate) did not experience a significantly lower breast cancer risk compared with women with normal cycle lengths (26-31 days) at that age [covariate-adjusted hazard ratio (HR), 0.92; 95% confidence interval (95% CI), 0.79-1.06]. Among women ages <40 years, those with menstrual cycles lasting >32 days or too irregular to estimate at ages 18 to 22 years had a decreased incidence of breast cancer (covariate-adjusted HR, 0.71; 95% CI, 0.53-0.97). Current menstrual cycle characteristics were not associated with breast cancer incidence. Conclusion: Overall, longer or irregular cycles at ages 18 to 22 years or in early adulthood were not associated with reduced premenopausal breast cancer risk. However, longer menstrual cycles at ages 18 to 22 years were associated with a lower incidence of premenopausal breast cancer before age 40.

[1]  I. D. Tonkelaar,et al.  Regularity and length of menstrual cycles in women aged 41–46 in relation to breast cancer risk: Results from the DOM-project , 2005, Breast Cancer Research and Treatment.

[2]  F. Clavel-Chapelon.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women , 2002, Cancer Causes & Control.

[3]  D. Grabrick,et al.  Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States) , 2002, Cancer Causes & Control.

[4]  JoAnn E Manson,et al.  Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. , 2003, Diabetes care.

[5]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[6]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[7]  W. Willett,et al.  Menstrual factors in relation to breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  S. Wild,et al.  Mortality of women with polycystic ovary syndrome at long-term follow-up. , 1998, Journal of clinical epidemiology.

[9]  D Spiegelman,et al.  Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. , 1998, American journal of epidemiology.

[10]  J. Manson,et al.  The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.

[11]  E. Negri,et al.  Association of Stein‐Leventhal Syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa , 1997, Cancer.

[12]  M. Pike,et al.  Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. , 1996, British Journal of Cancer.

[13]  I. den Tonkelaar,et al.  Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project. , 1996, Breast cancer research and treatment.

[14]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[15]  C. Weinberg,et al.  Menstrual cycle patterns and risk of breast cancer. , 1994, American journal of epidemiology.

[16]  B. Pasternack,et al.  The influence of medical conditions associated with hormones on the risk of breast cancer. , 1993, International journal of epidemiology.

[17]  C. la Vecchia,et al.  Lifelong menstrual pattern and risk of breast cancer. , 1993, Oncology.

[18]  L. Bernstein,et al.  Endogenous hormones and breast cancer risk. , 1993, Epidemiologic reviews.

[19]  W. Thompson,et al.  Polycystic ovaries and the risk of breast cancer. , 1991, American journal of epidemiology.

[20]  F. Greenspan.  Basic and Clinical Endocrinology , 1990 .

[21]  B. Henderson,et al.  Risk factors for breast cancer in Chinese women in Shanghai. , 1988, Cancer research.

[22]  M. Pike,et al.  Do regular ovulatory cycles increase breast cancer risk? , 1985, Cancer.

[23]  C. la Vecchia,et al.  Menstrual cycle patterns and the risk of breast disease. , 1985, European journal of cancer & clinical oncology.

[24]  J. Annegers,et al.  Chronic Anovulation Syndrome and Associated Neoplasia , 1983, Obstetrics and gynecology.

[25]  W. Poznanski.  Basic and Clinical Endocrinology. , 1982 .

[26]  J. Masters,et al.  Cyclic Variation of DNA synthesis in human breast epithelium. , 1977, Journal of the National Cancer Institute.

[27]  J. Meyer.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. , 1977, Human pathology.